FindTrial
Sign In

Retrospective Analysis of 0.01% Atropine Sulfate Eye Drops for Preventing Myopia Onset in Children

Retrospective Analysis of 0.01% Atropine Sulfate Eye Drops for Preventing Myopia Onset in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114828
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-02
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Low-concentration atropine prevention group:None
Control Group:None

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 6 to 12 years old; 2. Equivalent spherical refraction (ESR) under small pupil (without cycloplegia) in both eyes: +0.75D ~ -0.50D; 3. Astigmatism <= 1.0D; 4. Anisometropia <= 1.0D; 5. Having axial length data of at least 3 months before using atropine sulfate eye drops and at least 6 months after medication; or subjects who have not received any myopia prevention and control measures.

Exclusion criteria

Exclusion criteria: 1. History of ophthalmic surgery; 2. History of ocular diseases (e.g., amblyopia, strabismus, glaucoma); 3. Poor general health status (e.g., heart disease or respiratory system disease); 4. Concurrent use of other myopia prevention and control products;

Design outcomes

Primary

MeasureTime frame
Axial Length (AL);—

Secondary

MeasureTime frame
spherical equivalent(SE);—

Countries

China

Contacts

Public ContactJingjing Xu

Eye Hospital, Wenzhou Medical University

xujj@eye.ac.cn+86 577 8806 8166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026